Skip to main content

Table 2 IC50 values of tested compounds ± standard deviation against HepG-2

From: Design, efficient synthesis and molecular docking of some novel thiazolyl-pyrazole derivatives as anticancer agents

Compound No. IC50 (μg/mL) Compound No. IC50 (μg/mL)
Doxorubicin 3.07 ± 0.27 10a 2.20 ± 0.13
3a 4.39 ± 0.47 15a 12.5 ± 0.97
6d 3.90 ± 0.41 21 4.80 ± 0.56